Search Results 1681-1690 of 15588 for Orange Peel tea

1. A Study To Evaluate The Effectiveness And Safety Of Camidanlumab Tesirine (ADCT-301) In Patients With Relapsed Or Refractory Hodgkin Lymphoma - Mayo Clinic

   Active second primary malignancy other than non-melanoma skin cancers, non-metastatic prostate cancer, in situ cervical cancer, ductal or lobular carcinoma ...

2. Nivolumab In Treating Patients With Relapsed Or Refractory Peripheral T-cell Lymphoma - Mayo Clinic

   ... skin cancer or carcinoma-in-situ of the cervix. NOTE: if there is a history of prior malignancy, they must not be receiving other specific treatment for ...

3. Autologous, MUC1-Activated T Cells Expanded From Peripheral Blood In Patients With Relapsed And Resistant Ovarian Cancer - Mayo Clinic

   The purpose of this study determine the toxicity of in-house, manufactured MUC1-activated T cells in patients with relapsed/refractory MUC1-expressing ovarian ...

4. Namilumab In Subjects With Chronic Pulmonary Sarcoidosis - Mayo Clinic

   Sarcoidosis is a multi-organ autoimmune disease characterized by non-necrotizing granulomas believed to be formed from an exaggerated immune response to ...

5. A Study Of The Safety And Effectiveness Of Combined Toca 511 And Toca FC For Patients Having Removal Surgery For Recurring Glioblastoma Or Anaaplastic Astrocytoma - Mayo Clinic

   Adequately treated basal cell carcinoma or squamous cell skin cancer is acceptable regardless of time, as well as localized prostate carcinoma or cervical ...

6. Letrozole In Treating Postmenopausal Women Who Have Received Hormone Therapy For Hormone Receptor-Positive Breast Cancer - Mayo Clinic

   About this study. RATIONALE: Estrogen can cause the growth of breast cancer cells. Hormone therapy using letrozole may fight breast cancer by lowering the ...

7. A Study Of Lenvatinib For Treating Patients With Metastatic Or Advanced Pheochromocytoma Or Paraganglioma That Cannot Be Removed By Surgery - Mayo Clinic

   Symptomatic peripheral vascular disease. Other active malignancy ≤ 2 years prior to registration; EXCEPTIONS: non-melanotic skin cancer or carcinoma-in-situ ...

8. Transforaminal Lumbar Interbody Fusion (TLIF) - Mayo Clinic

   cell carcinoma of the skin and non-invasive squamous cell carcinoma localized only to the skin is allowed). - E.8 Overt or active bacterial infection ...

9. A Study To Analyze AVB-114 To Treat Complex Crohn’s Perianal Fistulas In Subjects With Quiescent Rectal Disease - Mayo Clinic

   History (within previous 5 years of screening visit) of invasive cancer including melanoma (with the exception of localized skin cancers). Subjects pregnant ...

10. Photoradiation With Verteporfin To Facilitate Immunologic Activity Of Pembrolizumab In Unresectable, Locally Advance Or Metastatic Pancreatic Cancer - Mayo Clinic

    About this study. We will study the effects of photodynamic priming for pancreatic adenocarcinoma treatment. Prior to study treatment, the patient will ...